Literature DB >> 29349535

Mycobacterium xenopi Genotype Associated with Clinical Phenotype in Lung Disease.

Takashi Hirama1,2,3, Alex Marchand-Austin4,5, Jennifer Ma5, David C Alexander6, Sarah K Brode7,8,9, Theodore K Marras7,8, Frances B Jamieson4,5.   

Abstract

Mycobacterium xenopi is responsible for pulmonary disease (PD) in Europe and Canada. Despite its high prevalence and increasing clinical importance, little is known about the genetic diversity of M. xenopi. Through a prospective study for M. xenopi strain type and the relation to clinical phenotype, 39 patients with M. xenopi PD were analyzed. Our study demonstrated that sequence type (ST) 5 was dominant in Ontario among 15 distinct STs and caused PD in people even without underlying lung disease, whereas disease due to non-ST5 was found almost exclusively in patients with underlying lung disease.

Entities:  

Keywords:  MLST; Mycobacterial disease; Mycobacterium xenopi; Non-tuberculous mycobacteria

Mesh:

Substances:

Year:  2018        PMID: 29349535     DOI: 10.1007/s00408-018-0087-9

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  9 in total

Review 1.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

2.  Comparison of the spectrum of radiologic and clinical manifestations of pulmonary disease caused by Mycobacterium avium complex and Mycobacterium xenopi.

Authors:  Maria C Carrillo; Demetris Patsios; Ute Wagnetz; Frances Jamieson; Theodore K Marras
Journal:  Can Assoc Radiol J       Date:  2013-12-08       Impact factor: 2.248

3.  Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France.

Authors:  C Andréjak; F-X Lescure; E Pukenyte; Y Douadi; Y Yazdanpanah; G Laurans; J-L Schmit; V Jounieaux
Journal:  Thorax       Date:  2008-12-03       Impact factor: 9.139

4.  The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study.

Authors:  Wouter Hoefsloot; Jakko van Ingen; Claire Andrejak; Kristian Angeby; Rosine Bauriaud; Pascale Bemer; Natalie Beylis; Martin J Boeree; Juana Cacho; Violet Chihota; Erica Chimara; Gavin Churchyard; Raquel Cias; Rosa Daza; Charles L Daley; P N Richard Dekhuijzen; Diego Domingo; Francis Drobniewski; Jaime Esteban; Maryse Fauville-Dufaux; Dorte Bek Folkvardsen; Noel Gibbons; Enrique Gómez-Mampaso; Rosa Gonzalez; Harald Hoffmann; Po-Ren Hsueh; Alexander Indra; Tomasz Jagielski; Frances Jamieson; Mateja Jankovic; Eefje Jong; Joseph Keane; Wo-Jung Koh; Berit Lange; Sylvia Leao; Rita Macedo; Turid Mannsåker; Theodore K Marras; Jeannette Maugein; Heather J Milburn; Tamas Mlinkó; Nora Morcillo; Kozo Morimoto; Dimitrios Papaventsis; Elia Palenque; Mar Paez-Peña; Claudio Piersimoni; Monika Polanová; Nalin Rastogi; Elvira Richter; Maria Jesus Ruiz-Serrano; Anabela Silva; M Pedro da Silva; Hulya Simsek; Dick van Soolingen; Nora Szabó; Rachel Thomson; Teresa Tórtola Fernandez; Enrico Tortoli; Sarah E Totten; Greg Tyrrell; Tuula Vasankari; Miguel Villar; Renata Walkiewicz; Kevin L Winthrop; Dirk Wagner
Journal:  Eur Respir J       Date:  2013-04-18       Impact factor: 16.671

5.  Multilocus sequence typing of Mycobacterium xenopi.

Authors:  David C Alexander; Theodore K Marras; Jennifer H Ma; Samia Mirza; Daniel Liu; Julianne V Kus; Hafid Soualhine; Vincent Escuyer; David Warshauer; Sarah K Brode; David J Farrell; Frances B Jamieson
Journal:  J Clin Microbiol       Date:  2014-09-10       Impact factor: 5.948

6.  Species-Specific Risk Factors, Treatment Decisions, and Clinical Outcomes for Laboratory Isolates of Less Common Nontuberculous Mycobacteria in Washington State.

Authors:  Emily S Ford; David J Horne; Javeed A Shah; Carolyn K Wallis; Ferric C Fang; Thomas R Hawn
Journal:  Ann Am Thorac Soc       Date:  2017-07

7.  Pulmonary Nontuberculous Mycobacteria-Associated Deaths, Ontario, Canada, 2001-2013.

Authors:  Theodore K Marras; Michael A Campitelli; Hong Lu; Hannah Chung; Sarah K Brode; Alex Marchand-Austin; Kevin L Winthrop; Andrea S Gershon; Jeffrey C Kwong; Frances B Jamieson
Journal:  Emerg Infect Dis       Date:  2017-03       Impact factor: 6.883

8.  Mycobacterium xenopi clinical relevance and determinants, the Netherlands.

Authors:  Jakko van Ingen; Martin J Boeree; Wiel C M de Lange; Wouter Hoefsloot; Saar A Bendien; Cecile Magis-Escurra; Richard Dekhuijzen; Dick van Soolingen
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883

9.  Pulmonary nontuberculous mycobacterial disease, Ontario, Canada, 1998-2010.

Authors:  Theodore K Marras; David Mendelson; Alex Marchand-Austin; Kevin May; Frances B Jamieson
Journal:  Emerg Infect Dis       Date:  2013-11       Impact factor: 6.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.